Hepatocellular adenoma diagnostic study of choice

Jump to: navigation, search

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma diagnostic study of choice

CDC on Hepatocellular adenoma diagnostic study of choice

Hepatocellular adenoma diagnostic study of choice in the news

Blogs on Hepatocellular adenoma diagnostic study of choice

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

The diagnostic approach of hepatocellular adenoma involves the use of radiological investigation with or without surgical resection and biopsy. Surgical resection and biopsy remains the gold standard for definitive diagnosis making.

Diagnostic Study of Choice

Study of Choice

References

  1. Adarsh Vijay, Ahmed Elaffandi & Hatem Khalaf (2015). "Hepatocellular adenoma: An update". World journal of hepatology. 7 (25): 2603–2609. doi:10.4254/wjh.v7.i25.2603. PMID 26557953. Unknown parameter |month= ignored (help)
  2. P. Herman, V. Pugliese, M. A. Machado, A. L. Montagnini, M. Z. Salem, T. Bacchella, L. A. D'Albuquerque, W. A. Saad, M. C. Machado & H. W. Pinotti (2000). "Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment". World journal of surgery. 24 (3): 372–376. PMID 10658075. Unknown parameter |month= ignored (help)
  3. P. Herman, V. Pugliese, M. A. Machado, A. L. Montagnini, M. Z. Salem, T. Bacchella, L. A. D'Albuquerque, W. A. Saad, M. C. Machado & H. W. Pinotti (2000). "Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment". World journal of surgery. 24 (3): 372–376. PMID 10658075. Unknown parameter |month= ignored (help)
  4. Ludger Barthelmes & Iain S. Tait (2005). "Liver cell adenoma and liver cell adenomatosis". HPB : the official journal of the International Hepato Pancreato Biliary Association. 7 (3): 186–196. doi:10.1080/13651820510028954. PMID 18333188.
  5. Ludger Barthelmes & Iain S. Tait (2005). "Liver cell adenoma and liver cell adenomatosis". HPB : the official journal of the International Hepato Pancreato Biliary Association. 7 (3): 186–196. doi:10.1080/13651820510028954. PMID 18333188.

Linked-in.jpg